Actively Recruiting
Clinical Efficacy of Nobel Parallel CC Implants With on1 Abutment in Posterior Area Participants
Led by The Dental Hospital of Zhejiang University School of Medicine · Updated on 2024-04-01
48
Participants Needed
1
Research Sites
274 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
1. Research background NobelBiocare manufacture put forward a new abutment called on1. This concept is based on a two-stage abutment in which the on1 abutment is placed directly on the implant during surgery and will not be disconnected since then. At present, there are very a few clinical prospective studies about clinical effect of Nobelparallel CC implant combined with on1 abutment. 2. Research objective This study will evaluate the clinical efficacy of Nobel parallel with on1 abutment compared to traditional healing cap in posterior teeth in a short term(one year) and long trem (five year) follow-up. 3. Study design and methods: Design type: prospective clinical study. Study duration: 5 years Start time: From the date of adoption of ethics. End time: 2026. Follow up examination: Panoramic images will be taken at all times to measure the marginal bone level of the implant. Clinical examination and questionnaire survey will be conducted to obtain the implant conditions and patients' satisfaction. Periodontal indexes such as keratinized gingival width, plaque index, gingival index, bleeding on probe, probing depth of peri-implant tissue will be evaluate.
CONDITIONS
Official Title
Clinical Efficacy of Nobel Parallel CC Implants With on1 Abutment in Posterior Area Participants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- At least 18 years old and able to undergo dental implant surgery without medical contraindications
- Planned single implant placement with Nobel Parallel CC in the posterior maxillary or mandibular teeth
- No need for additional bone augmentation
- Sufficient space for abutment and future prosthesis placement
- Willing to adhere to follow-up visits
You will not qualify if you...
- Uncontrolled systemic diseases such as blood pressure over 180/100 mmHg or recent heart attack within six months
- Use of bisphosphonate drugs within the past three months
- Heavy smoking (10 or more cigarettes per day), alcoholism, or drug abuse
- Uncontrolled periodontitis
- Infection at the implant site
- Pregnancy or breastfeeding
- Severe malocclusion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Affiliated Stomatology Hospital, Zhejiang University School of Medicine, 166 North Qiu'tao Road
Hangzhou, Zhejiang, China, 310000
Actively Recruiting
Research Team
F
Fuming He, PhD
CONTACT
J
Jimin Jiang, Master
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here